FEBS Letters · 1997 · 354 citations · 7 references
Fluconazole resistance occurs in > 10% of cases of candidosis during the late stages of AIDS. We show here in two clinical isolates that resistance was caused by defective sterol delta5,6-desaturation. This altered the type of sterol accumulating under fluconazole treatment from 14alpha-methylergosta-8,24(28)-dien-3beta,6alpha -diol to 14alpha-methylfecosterol which is capable of supporting growth. A consequence of this mechanism of azole resistance is that an absence of ergosterol causes cross-resistance to the other major antifungal agent available, amphotericin B. The results also show that growth arrest after fluconazole treatment of C. albicans in clinical conditions is caused by 14alpha-methylergosta-8,24(28)-dien-3beta,6alpha -diol accumulation.
7
Dominique Sanglard, Karl Kuchler, Françoise Ischer et al. · Antimicrobial Agents and Chemotherapy · 1995 · 814 citations · Full text
Specific Multidrug Transporters, Antifungal Agent, Azole Resistance +15
Steven L. Kelly, David C. Lamb, Andrew J. Corran et al. · Biochemical and Biophysical Research Communications · 1995 · 294 citations
Polyene antibiotic - sterol interaction.
Anthony W. Norman, Anna M. Spielvogel, Richard G. Wong · PubMed · 1976 · 185 citations
Pharmaceutical Science, Bioorganic Chemistry, Engineering +19
Fluconazole-resistant candidosis in an HIV cohort
Guy Baily, Fiona Perry, David W. Denning et al. · AIDS · 1994 · 131 citations